Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver

HPB

Volumn 10, Issue 6, 2008, Pages 396-404

  Artinyan, Avo ^a   Nelson, Rebecca ^a   Soriano, Perry ^a   Chung, Vincent ^a   Retseck, Janet ^a   Reynolds, Jonathon ^a   Marx, Howard ^a   Kim, Joseph ^a   Wagman, Lawrence ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b ST JOSEPH HOSPITAL   (United States)

Author keywords

Chemoembolization; RECIST; Regional therapy

Indexed keywords

CISPLATIN; DOXORUBICIN; ETHIODIZED OIL; MITOMYCIN; POLYVINYL ALCOHOL;

AGED; ARTICLE; ARTIFICIAL EMBOLISM; CARCINOID; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PREDICTION; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 57049136773     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820802356564     Document Type: Article

References (39)

1. Llovet, JM. (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol, 40:3, pp. 225-235.
2. Liapi, E. and Geschwind, JF. (2007) Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol, 25:8, pp. 978-986.
3. Stuart, K. (2003) Chemoembolization in the management of liver tumors. Oncologist, 8:5, pp. 425-437.
4. Sullivan, KL. (2002) Hepatic artery chemoembolization. Semin Oncol, 29:2, pp. 145-151.
5. Patt, YZ, Chuang, VP, Wallace, S., Benjamin, RS, Fuqua, R. and Mavligit, GM. (1983) Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver. Cancer, 51:8, pp. 1359-1363.
6. Takayasu, K., Shima, Y., Muramatsu, Y., Moriyama, N., Yamada, T. Makuuchi, M. et al. (1987) Hepatocellular carcinoma: Treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology, 163:2, pp. 345-351.
7. Takayasu, K., Suzuki, M., Uesaka, K., Muramatsu, Y., Moriyama, N. Yoshida, T. et al. (1989) Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and risk factors. Cancer Chemother Pharmacol, 23, p. S123.
8. Shimamura, Y., Gunven, P., Takenaka, Y., Shimizu, H., Shima, Y. Akimoto, H. et al. (1988) Combined peripheral and central chemoembolization of liver tumors. Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE). Cancer, 61:2, pp. 238-242.
9. Kanematsu, T., Inokuchi, K., Sugimachi, K., Furuta, T., Sonoda, T. Tamura, S. et al. (1984) Selective effects of Lipiodolized antitumor agents. J Surg Oncol, 25:3, pp. 218-226.
10. Okamura, J., Horikawa, S., Fujiyama, T., Monden, M., Kambayashi, J. Sikujara, O. et al. (1982) An appraisal of transcatheter arterial embolization combined with transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies. World J Surg, 6:3, pp. 352-357.
11. Llovet, JM, Real, MI, Montana, X., Planas, R., Coll, S. Aponte, J. et al. (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomized controlled trial. Lancet, 359:9319, pp. 1734-1739.
12. Solomon, B., Soulen, MC, Baum, RA, Haskal, ZJ, Shlansky-Goldberg, RD and Cope, C. (1999) Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a US population. J Vasc Interv Radiol, 10:6, pp. 793-798.
13. Therasse, P., Arbuck, SG, Eisenhauer, EA, Wanders, J., Kaplan, RS Rubinstein, L. et al. (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst, 92:3, pp. 205-216.
14. Oken, MM, Creech, RH, Tormey, DC, Horton, J., Davis, TE McFadden, ET et al. (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol, 5:6, pp. 649-655.
15. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med, 332:19, pp. 1256-1261.
16. Ikeda, K., Saitoh, S., Koida, I., Tsubota, A., Arase, Y. Chayama, K. et al. (1995) A prospective randomized evaluation of a compound of tegafur and uracil as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Am J Clin Oncol, 18:3, pp. 204-210.
17. Wu, CC, Ho, YZ, Ho, WL, Wu, TC, Liu, TJ and P'eng, FK. (1995) Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal. Br J Surg, 82:1, pp. 122-126.
18. Izumi, R., Shimizu, K., Iyobe, T., Ii, T, Yagi, M. Matsui, O. et al. (1994) Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology, 20:2, pp. 295-301.
19. Llovet, JM and Bruix, J. (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology, 37:2, pp. 429-442.
20. Michaelis, LC and Ratain, MJ. (2006) Measuring response in a post-RECIST world: From black and white to shades of grey. Nat Rev Cancer, 6:5, pp. 409-414.
21. Rosner, GL, Stadler, W. and Ratain, MJ. (2002) Randomized discontinuation design: Application to cytostatic antineoplastic agents. J Clin Oncol, 20:22, pp. 4478-4484.
22. Escudier, B., Eisen, T., Stadler, WM, Szczylik, C., Oudard, S. Siebels, M. et al. (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med, 356:2, pp. 125-134.
23. Yang, JC, Haworth, L., Sherry, RM, Hwu, P., Schwartzentruber, DJ Topalian, SL et al. (2003) A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med, 349:5, pp. 427-434.
24. Lo, CM, Ngan, H., Tso, WK, Liu, CL, Lam, CM Poon, RT et al. (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology, 35:5, pp. 1164-1171.
25. Abramson, RG, Rosen, MP, Perry, LJ, Brophy, DP, Raeburn, SL and Stuart, KE. (2000) Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy. Radiology, 216:2, pp. 485-491.
26. Popov, I., Lavrnic, S., Jelic, S., Jezdic, S. and Jasovic, A. (2002) Chemoembolization for liver metastases from colorectal carcinoma: Risk or a benefit. Neoplasma, 49:1, pp. 43-48.
27. Vogl, TJ, Zangos, S., Eichler, K., Yakoub, D. and Nabil, M. (2007) Colorectal liver metastases: Regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: An update. Eur Radiol, 17:4, pp. 1025-1034.
28. Tellez, C., Benson III, AB, Lyster, MT, Talamonti, M., Shaw, J. Braun, MA et al. (1998) Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer, 82:7, pp. 1250-1259.
29. Lang, EK and Brown Jr, CL (1993) Colorectal metastases to the liver: selective chemoembolization. Radiology, 189:2, pp. 417-422.
30. Bedikian, AY, Legha, SS, Mavligit, G., Carrasco, CH, Khorana, S. Plager, C. et al. (1995) Treatment of uveal melanoma metastatic to the liver: A review of the M.D. Anderson Cancer Center experience and prognostic factors. Cancer, 76:9, pp. 1665-1670.
31. Vogl, T., Eichler, K., Zangos, S., Herzog, C., Hammerstingl, R. Balzer, J. et al. (2007) Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: Local tumor control and survival. J Cancer Res Clin Oncol, 133:3, pp. 177-184.
32. Mavligit, GM, Charnsangavej, C., Carrasco, CH, Patt, YZ, Benjamin, RS and Wallace, S. (1988) Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA, 260:7, pp. 974-976.
33. Burger, I., Hong, K., Schulick, R., Georgiades, C., Thuluvath, P. Choti, M. et al. (2005) Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: Initial experience in a single institution. J Vasc Interv Radiol, 16:3, pp. 353-361.
34. Giroux, MF, Baum, RA and Soulen, MC. (2004) Chemoembolization of liver metastasis from breast carcinoma. J Vasc Interv Radiol, 15:3, pp. 289-291.
35. Ruszniewski, P. and O'Toole, D. (2004) Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors. Neuroendocrinology, 80, pp. 74-78.
36. Therasse, E., Breittmayer, F., Roche, A., De, BT, Indushekar, S. Ducreux, M. et al. (1993) Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology, 189:2, pp. 541-547.
37. Ruszniewski, P., Rougier, P., Roche, A., Legmann, P., Sibert, A. Hochlaf, S. et al. (1993) Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer, 71:8, pp. 2624-2630.
38. Clouse, ME, Perry, L., Stuart, K. and Stokes, KR. (1994) Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestion, 55, pp. 92-97.
39. Ruutiainen, AT, Soulen, MC, Tuite, CM, Clark, TW, Mondschein, JI Stavropoulos, SW et al. (2007) Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol, 18:7, pp. 847-855.